首頁 > 市場調查報告書 > 製藥

藥物開發以基因為基之藥物開發人工智能人工智能藥物研發

市場調查報告書

商品編碼

2075876

全球人工智慧市場體學學研究：按產品、技術平台、應用、最終用戶和地區分類

Global AI in Omics Studies Market, By Offering, By Technology Platform, By Application, By End User, By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球體學研究領域的人工智慧市場預計到 2026 年將達到 148.09 億美元，預計到 2033 年將達到 105.618 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 32.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1,480,900,000 美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	32.40%	2033年市場規模預測：	105.618億美元

由於人工智慧在基因組學、蛋白質組學和代謝體學等各種體學領域的應用日益廣泛，全球體學研究領域的人工智慧市場預計將顯著成長。人工智慧工具被廣泛應用於巨量資料分析和精準醫療，以深入了解疾病並為患者開發個人化療法。此外，人工智慧分析海量體學資料集和識別複雜模式的能力，正推動其在藥物發現和個人化醫療等領域的應用。

市場動態：

全球體學研究領域人工智慧市場的主要促進因素包括製藥公司加大對人工智慧藥物研發的投資、精準醫療需求不斷成長以及政府對體學研究的資助增加。此外，體學數據量日益成長，以及有效利用這些數據的需求，也推動了人工智慧的應用。然而，對資料隱私和安全的擔憂、對新技術的抵觸情緒以及人工智慧專業人才的短缺，都在阻礙市場成長。另一方面，基於雲端的體學數據分析平台的出現以及人工智慧和醫療保健領域新創企業生態系統的擴張，有望為市場參與者創造巨大的成長機會。

此外，近年來，次世代定序技術的出現以及定量蛋白質體學和代謝體學技術的進步徹底改變了體學研究。這些高通量技術使得以前所未有的規模和速度產生大量多體學資料成為可能。全基因測序和全EXOME定序等技術不僅擴大用於研究，而且在臨床診斷和預後預測中也被廣泛應用。核糖核酸（RNA）定序等技術能夠進行單細胞層次的轉錄組分析，從而提供關於特定細胞類型和疾病狀態的詳細資訊。 SWATH-MS等蛋白質體學技術正在提高蛋白質分析的全面性和定量能力。代謝體學技術現在可以同時鑑定和定量生物檢體中的多種代謝物。定量體學技術的這些進步正在加速整合多組體學研究，並為生物系統提供更深入的見解。未來幾年，此類大規模、定量和整合的體學資料集的出現有望在疾病機制、生物標記和治療標靶方面帶來重大發現和深刻見解。這將進一步加速基於體學的研究和在各個疾病領域的應用。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數分析了全球人工智慧市場體學研究領域的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
《體學研究中的人工智慧》全球市場報告的目標受群眾外包括該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用各種策略矩陣來簡化決策過程，這些矩陣用於分析全球體學研究中的人工智慧市場。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Thermo Fisher Scientific
- Agilent Technologies
- Illumina
- BGI Genomics
- Dassault Systemes
- Qiagen
- Waters Corporation
- GE Healthcare
- Amazon Web Services, Inc
- Bruker
- Danaher
分析師意見

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6516

Global AI in Omics Studies Market is estimated to be valued at USD 1,480.9 Mn in 2026 and is expected to reach USD 10,561.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 32.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,480.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	32.40%	2033 Value Projection:	USD 10,561.8 Mn

The global AI in omics studies market is expected to see significant growth due to the increasing adoption of artificial intelligence in various omics fields such as genomics, proteomics, and metabolomics. AI tools are being widely used for big data analytics and precision medicine to gain deeper insights into diseases and develop personalized treatment options for patients. The ability of AI to analyze massive omics datasets and identify complex patterns is also propelling its usage in areas like drug discovery and personalized therapeutics.

Market Dynamics:

The key drivers fueling the global AI in omics studies market include growing investments by pharmaceutical companies in AI for drug discovery, rising demand for precision medicine, and increasing government funding for omics research. Additionally, the growing volumes of omics data being generated and the need to leverage this data effectively are driving the adoption of AI. However, data privacy and security concerns, reluctance to adopt new technologies, and a lack of a skilled AI workforce are some of the factors hindering market growth. Meanwhile, the emergence of cloud-based omics data analytics platforms and the expansion of the startup ecosystem in the AI and healthcare spaces are expected to create significant growth opportunities for market players.

Moreover, with the advent of next-generation sequencing and advancements in quantitative proteomics and metabolomics technologies, omics studies have been revolutionized in recent years. These high-throughput technologies have enabled the generation of massive amounts of multi-omics data at an unprecedented scale and speed. Technologies like whole genome and whole exome sequencing are increasingly used not just for research purposes but also in clinical settings for diagnostics and prognostics. Technologies such as Ribonucleic acid sequencing have enabled the profiling of transcriptomes at the single-cell level, providing details into specific cell types, disease conditions, etc. Proteomics technologies like SWATH-MS have improved protein coverage and quantitation capabilities. Metabolomics technologies are now capable of identifying and quantifying several metabolites simultaneously from biological samples. These advancing quantitative omics technologies are facilitating multi-omics integration studies and providing deeper insights into biological systems. The availability of such large-scale, quantitative, and integrated omics datasets is expected to drive significant discovery and insights into disease mechanisms, biomarkers, and therapeutic targets in the coming years. This will further fuel the growth in omics based research and applications across various disease areas.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global AI in omics studies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Illumina, BGI Genomics, Dassault Systemes, Qiagen, Waters Corporation, GE Healthcare, Amazon Web Services, Inc., Bruker, and Danaher
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global AI in omics studies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in omics studies market

Detailed Segmentation:

Global AI in Omics Studies Market, By Offering (Revenue, USD Mn, 2021 - 2033)
Software
Services
Global AI in Omics Studies Market, By Technology Platform (Revenue, USD Mn, 2021 - 2033)
Sequencing
Epigenomics
Proteomics
Metabolomics
Others (Transcriptomics, among others)
Global AI in Omics Studies Market, By Application (Revenue, USD Mn, 2021 - 2033)
Oncology
Infectious Diseases
Neurology
Cardiovascular Diseases
Immunology
Others (Pharmacogenomics, among others)
Global AI in Omics Studies Market, By End User (Revenue, USD Mn, 2021 - 2033)
Academic and Research Institutes
Biopharmaceutical Company
Others (Contract Research Organizations, among others)
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in the Global AI in omics studies Market:
Thermo Fisher Scientific.
Agilent Technologies
Illumina
BGI Genomics
Dassault Systemes
Qiagen
Waters Corporation
GE Healthcare
Amazon Web Services, Inc
Bruker
Danaher

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global AI in Omics Studies Market, By Offering
- Global AI in Omics Studies Market, By Technology Platform
- Global AI in Omics Studies Market, By Application
- Global AI in Omics Studies Market, By End User
- Global AI in Omics Studies Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing genetic/genomic data and increasing investments
- High setup costs and lack of infrastructure
- Scope for AI in drug discovery and vaccine development
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global AI in Omics Studies Market, By Offering, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global AI in Omics Studies Market, By Technology Platform, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Epigenomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Metabolomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Transcriptomics, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global AI in Omics Studies Market, By Application, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Pharmacogenomics, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global AI in Omics Studies Market, By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Biopharmaceutical Company
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Contract Research Organizations, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

8. Global AI in Omics Studies Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profile
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Agilent Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Illumina
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- BGI Genomics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Dassault Systemes
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Qiagen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
  - Strategies
- Waters Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GE Healthcare
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Amazon Web Services, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bruker
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Danaher
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views